114 related articles for article (PubMed ID: 31535397)
21. The toll-like receptor 4 antagonist transforming growth factor-β-activated kinase(TAK)-242 attenuates taurocholate-induced oxidative stress through regulating mitochondrial function in mice pancreatic acinar cells.
Pan LF; Yu L; Wang LM; He JT; Sun JL; Wang XB; Bai ZH; Su LJ; Pei HH
J Surg Res; 2016 Dec; 206(2):298-306. PubMed ID: 27884323
[TBL] [Abstract][Full Text] [Related]
22. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.
Sootichote R; Thuwajit P; Singsuksawat E; Warnnissorn M; Yenchitsomanus PT; Ithimakin S; Chantharasamee J; Thuwajit C
BMC Cancer; 2018 Feb; 18(1):231. PubMed ID: 29486738
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells.
Güney Eskiler G; Deveci Özkan A; Kaleli S; Bilir C
J Pharm Pharm Sci; 2019; 22(1):281-291. PubMed ID: 31287789
[TBL] [Abstract][Full Text] [Related]
24. TLR4 inhibitor resatorvid provides neuroprotection in experimental traumatic brain injury: implication in the treatment of human brain injury.
Zhang D; Li H; Li T; Zhou M; Hao S; Yan H; Yu Z; Li W; Li K; Hang C
Neurochem Int; 2014 Sep; 75():11-8. PubMed ID: 24858944
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 4 inhibitor TAK-242 treatment does not influence perfusion recovery in tissue ischemia.
van den Borne P; Bastiaansen AJ; de Vries MR; Quax PH; Hoefer IE; Pasterkamp G
J Cardiovasc Pharmacol; 2014 Jan; 63(1):16-22. PubMed ID: 24084220
[TBL] [Abstract][Full Text] [Related]
26. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
27. Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-κB Signaling Pathways.
Korashy HM; Maayah ZH; Al Anazi FE; Alsaad AM; Alanazi IO; Belali OM; Al-Atawi FO; Alshamsan A
Anticancer Res; 2017 Sep; 37(9):4899-4909. PubMed ID: 28870911
[TBL] [Abstract][Full Text] [Related]
28. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
30. TAK-242 Protects Against Apoptosis in Coronary Microembolization-Induced Myocardial Injury in Rats by Suppressing TLR4/NF-κB Signaling Pathway.
Wang XT; Lu YX; Sun YH; He WK; Liang JB; Li L
Cell Physiol Biochem; 2017; 41(4):1675-1683. PubMed ID: 28359050
[TBL] [Abstract][Full Text] [Related]
31. Anthocyanins Isolated from
Paramanantham A; Kim MJ; Jung EJ; Kim HJ; Chang SH; Jung JM; Hong SC; Shin SC; Kim GS; Lee WS
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784919
[TBL] [Abstract][Full Text] [Related]
32. TAK-875 Mitigates
Chen X; Yan Y; Weng Z; Chen C; Lv M; Lin Q; Du Q; Shen X; Yang L
J Diabetes Res; 2019; 2019():5487962. PubMed ID: 31934590
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose.
Hu L; Yang H; Ai M; Jiang S
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2199-2210. PubMed ID: 28808786
[TBL] [Abstract][Full Text] [Related]
34. A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line.
Mqoco T; Stander A; Engelbrecht AM; Joubert AM
Biomed Res Int; 2019; 2019():1850462. PubMed ID: 31886177
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.
Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907
[TBL] [Abstract][Full Text] [Related]
36. Early TLR4 inhibition reduces hippocampal injury at puberty in a rat model of neonatal hypoxic-ischemic brain damage via regulation of neuroimmunity and synaptic plasticity.
Tang Z; Cheng S; Sun Y; Zhang Y; Xiang X; Ouyang Z; Zhu X; Wang B; Hei M
Exp Neurol; 2019 Nov; 321():113039. PubMed ID: 31442443
[TBL] [Abstract][Full Text] [Related]
37. Novel small molecule decreases cell proliferation, migration, clone formation, and gene expression through ERK inhibition in MCF-7 and MDA-MB-231 breast cancer cell lines.
Hatzidaki E; Parsonidis P; Apostolou P; Daikopoulou V; Papasotiriou I
Anticancer Drugs; 2019 Jul; 30(6):618-627. PubMed ID: 30741723
[TBL] [Abstract][Full Text] [Related]
38. Aloe vera inhibits proliferation of human breast and cervical cancer cells and acts synergistically with cisplatin.
Hussain A; Sharma C; Khan S; Shah K; Haque S
Asian Pac J Cancer Prev; 2015; 16(7):2939-46. PubMed ID: 25854386
[TBL] [Abstract][Full Text] [Related]
39. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
40. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
